BrightSpring Health Services (NASDAQ:BTSG – Get Free Report) and Cancer Treatment (OTCMKTS:CTHZ – Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation.
Valuation and Earnings
This table compares BrightSpring Health Services and Cancer Treatment”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
BrightSpring Health Services | $10.59 billion | 0.29 | -$154.60 million | ($0.26) | -67.23 |
Cancer Treatment | N/A | N/A | N/A | N/A | N/A |
Cancer Treatment has lower revenue, but higher earnings than BrightSpring Health Services.
Analyst Ratings
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
BrightSpring Health Services | 0 | 1 | 9 | 0 | 2.90 |
Cancer Treatment | 0 | 0 | 0 | 0 | 0.00 |
BrightSpring Health Services presently has a consensus price target of $21.67, indicating a potential upside of 23.95%. Given BrightSpring Health Services’ stronger consensus rating and higher possible upside, analysts clearly believe BrightSpring Health Services is more favorable than Cancer Treatment.
Volatility & Risk
BrightSpring Health Services has a beta of 2.2, suggesting that its stock price is 120% more volatile than the S&P 500. Comparatively, Cancer Treatment has a beta of -2.37, suggesting that its stock price is 337% less volatile than the S&P 500.
Profitability
This table compares BrightSpring Health Services and Cancer Treatment’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
BrightSpring Health Services | -0.38% | 4.16% | 0.99% |
Cancer Treatment | N/A | N/A | N/A |
Summary
BrightSpring Health Services beats Cancer Treatment on 7 of the 8 factors compared between the two stocks.
About BrightSpring Health Services
BrightSpring Health Services, Inc. operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations. It serves patients through clinical providers and pharmacists. The company was formerly known as Phoenix Parent Holdings Inc. and changed its name to BrightSpring Health Services, Inc. in May 2021. BrightSpring Health Services, Inc. was founded in 1974 and is headquartered in Louisville, Kentucky.
About Cancer Treatment
Cancer Treatment Holdings, Inc., through its subsidiaries, engages in providing IT-enabled services; the exploitation of an invention related to the on-site production of chlorine gas and related compounds; and providing radiation therapy, diagnostic imaging, and other medical related services. The company, through a 50% interest in a joint venture, offers IT-enabled services, including medical transcriptions, billing and collecting, bookkeeping, and claims processing services. The company enables users to manufacture chlorine on-site and when needed through its device. It has a 51% interest in a radiation therapy center located in Logan, West Virginia. In addition, through its wholly owned subsidiary, CTI Management Corp., the company’s president provides management services. The company was incorporated in 1986 and is based in Carson City, Nevada.
Receive News & Ratings for BrightSpring Health Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BrightSpring Health Services and related companies with MarketBeat.com's FREE daily email newsletter.